Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Marmarelis, ME"'
Autor:
Pennell, NA, Clarke, JM, Liu, S, Gutierrez, M, Batus, M, Bauman, J, Fidler, MJ, Marmarelis, ME, Feliciano, J, Barzi, A, Lopes, G, Molife, C, Verma, S, Stefaniak, VJ, Winfree, KB, Belli, A, Cui, Z, Kim, S, Manion, C, Afolabi, M, Caria, N, Bonomi, P
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S333-S333
Autor:
Marks JA; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: jennifer_marks@dfci.harvard.edu., Gandhi N; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ 85040 USA. Electronic address: ngandhi@carisls.com., Halmos B; Montefiore Medical Center, Albert Einstein Cancer Center, 1575 Blondell Ave, Bronx, NY 10461, USA. Electronic address: bahalmos@montefiore.org., Marmarelis ME; University of Pennsylvania, 3400 Civic Center Boulevard West Pavilion, 2nd Floor, Philadelphia, PA 19104, USA. Electronic address: melina.marmarelis@pennmedicine.upenn.edu., Yeon Kim S; Yale University, 333 Cedar St, New Haven, CT 06510, USA. Electronic address: soyeon.kim@yale.edu., Bazhenova L; University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive, San Diego, CA 92037, USA. Electronic address: lbazhenova@health.ucsd.edu., Ramalingam SS; Winship Cancer Institute of Emory University, 1365 Clifton Rd NE Building C, Atlanta, GA 30322, USA. Electronic address: ssramal@emory.edu., Xiu J; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ 85040 USA. Electronic address: jxiu@carisls.com., Walker P; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ 85040 USA. Electronic address: pwalker@carisls.com., Oberley MJ; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ 85040 USA. Electronic address: moberley@carisls.com., Ma PC; Penn State Cancer Institute, 400 University Dr, Hershey, PA 17033, USA. Electronic address: patrickma@pennstatehealth.psu.edu., Liu SV; Georgetown University, 3800 Reservoir Rd NW, Washington, D.C 20007, USA. Electronic address: stephen.v.liu@gunet.georgetown.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Sep 02; Vol. 196, pp. 107935. Date of Electronic Publication: 2024 Sep 02.
Publikováno v:
PloS one [PLoS One] 2024 Aug 29; Vol. 19 (8), pp. e0309769. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).
Autor:
Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Scholes DG; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., McWilliams TL; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Hwang WT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Kosteva J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Costello MR; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Singh AP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Lau-Min KS; Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, MA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Gabriel PE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Martella AO; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Roy MA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thompson JC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Pulmonary Medicine and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Dougherty DW; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Shulman LN; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Langer CJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bekelman JE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jul 03, pp. OP2400070. Date of Electronic Publication: 2024 Jul 03.
Autor:
Mathew D; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Marmarelis ME; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Foley C; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bauml JM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ye D; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ghinnagow R; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ngiow SF; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Klapholz M; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jun S; Department of Radiation Oncology and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Zhang Z; Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA., Zorc R; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Davis CW; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Diehn M; Department of Radiation Oncology and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Giles JR; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang AC; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhang NR; Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA., Schoenfeld AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carpenter EL; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Langer CJ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wherry EJ; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Minn AJ; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Jun 21; Vol. 384 (6702), pp. eadf1329. Date of Electronic Publication: 2024 Jun 21.
Autor:
Leighl NB; Princess Margaret Cancer Centre, Toronto, ON, Canada., Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama, Japan., Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., Cheng Y; Jilin Cancer Hospital, Changchun, China., Minchom AR; Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Marmarelis ME; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR., Chih-Hsin Yang J; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Liu B; Harbin Medical University Cancer Hospital, Harbin, China., John T; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Massutí B; Alicante University Dr. Balmis Hospital, ISABIAL, Alicante, Spain., Spira AI; Virginia Cancer Specialists, Fairfax, VA., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Wang J; Fudan University Shanghai Cancer Center, Shanghai, China., Li J; Sichuan Cancer Hospital, Sichuan, China., Liu C; Shengjing Hospital of China Medical University, Shenyang, China., Novello S; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano (TO), Italy., Kondo M; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Korbenfeld E; British Hospital of Buenos Aires-Central British Hospital, Buenos Aires, Argentina., Moskovitz M; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Han JY; National Cancer Center, Goyang, Republic of Korea., Alexander M; Medical University of South Carolina, Charleston, SC., Joshi R; Cancer Research SA, Adelaide, SA, Australia., Felip E; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VIHO), Universitat Autonoma de Barcelona, Barcelona, Spain., Voon PJ; Department of Radiotherapy and Oncology, Sarawak General Hospital, Kuching, Malaysia., Danchaivijitr P; Siriraj Hospital, Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand., Hsu PC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan., Silva Melo Cruz FJ; Núcleo de Ensino e Pequisa, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil., Wehler T; University Hospital of Giessen and Marburg, Giessen and Marburg, Germany., Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France., Teixeira E; Medical Oncology, Hospital CUF Descobertas, Lisboa, Portugal., Nguyen D; City of Hope National Medical Center, Duarte, CA., Sabari JK; Perlmutter Cancer Center, New York University Langone Health, New York, NY., Qin A; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Kowalski D; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Şendur MAN; Department of Medical Oncology, Ankara Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey., Xie J; Janssen Research & Development, Raritan, NJ., Ghosh D; Janssen Research & Development, Raritan, NJ., Alhadab A; Janssen Research & Development, San Diego, CA., Haddish-Berhane N; Janssen Research & Development, Spring House, PA., Clemens PL; Janssen Research & Development, Spring House, PA., Lorenzini P; Janssen Research & Development, Spring House, PA., Verheijen RB; Janssen Research & Development, Leiden, the Netherlands., Gamil M; Janssen Research & Development, Spring House, PA., Bauml JM; Janssen Research & Development, Spring House, PA., Baig M; Janssen Research & Development, Raritan, NJ., Passaro A; European Institute of Oncology IRCCS, Milano, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 10, pp. JCO2401001. Date of Electronic Publication: 2024 Jun 10.
Autor:
Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Scholes DG; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., McGrath CM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Priore SF; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Roth JJ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Feldman M; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Morrissette JJD; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Litzky L; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Deshpande C; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA., Thompson JC; Department of Pulmonary Medicine and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Gabriel PE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Singh AP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Langer CJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA. Electronic address: Charu.aggarwal@pennmedicine.upenn.edu.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2024 May; Vol. 25 (3), pp. 262-265.e2. Date of Electronic Publication: 2024 Mar 12.
Autor:
Barsouk A; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: Adam.barsouk@pennmedicine.upenn.edu., Friedes C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Iocolano M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Doucette A; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Robinson KW; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., D'Avella CA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Marmarelis ME; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Kosteva JA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Singh AP; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Ciunci CA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Levin WP; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Cengel KA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Bradley JD; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Feigenberg SJ; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Langer CJ; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Yegya-Raman N; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: Nikhil.Yegya-Raman@pennmedicine.upenn.edu.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2024 May; Vol. 25 (3), pp. e161-e171. Date of Electronic Publication: 2023 Dec 22.
Autor:
Yegya-Raman N; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Berman AT; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Ciunci CA; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Friedes C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Berlin E; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Iocolano M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Wang X; Department of Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Lai C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Levin WP; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Cengel KA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., O'Reilly SE; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Cohen RB; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Aggarwal C; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Marmarelis ME; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Singh AP; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Sun L; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Bradley JD; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Plastaras JP; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Simone CB 2nd; New York Proton Center, New York, New York; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Langer CJ; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Feigenberg SJ; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: steven.feigenberg@pennmedicine.upenn.edu.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 May 01; Vol. 119 (1), pp. 56-65. Date of Electronic Publication: 2023 Aug 29.
Autor:
Friedes C; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: cole.friedes@pennmedicine.upenn.edu., Iocolano M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Lee SH; Division of Physics, Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Li B; Division of Physics, Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Duan L; Division of Physics, Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Levin WP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Cengel KA; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Sun LL; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Aggarwal C; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Marmarelis ME; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Doucette A; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Cohen RB; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Xiao Y; Division of Physics, Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Langer CJ; Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Bradley J; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Feigenberg SJ; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: nikhil.yegya-raman@pennmedicine.upenn.edu.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1435-1444. Date of Electronic Publication: 2023 Oct 21.